Search results
Moderna (MRNA) Stock Outperformed Industry YTD: Here's Why
Zacks via Yahoo Finance· 7 days agoBeing one of the handful of makers of a COVID-19 vaccine, Moderna reaped the benefits of the...
The Moderna Selloff Gains Steam. An Analyst Has a Few Theories Why.
Barrons.com· 6 days agoThe stock was down 5.5% Wednesday morning, bringing the stocks losses to 13% since the market closed...
US nears deal to fund Moderna's bird flu vaccine trial, FT reports By Reuters
Investing.com· 5 days agoModerna and the U.S. Department of Health and Human Services (HHS) did not...talks with CSL...
1 Beaten-Down S&P 500 Dividend Stock to Buy in June and Hold For a Decade or Longer
Motley Fool via Yahoo Finance· 2 hours agoIn April, Pfizer showed us positive phase 3 results from a trial with adults aged 18 to 59 years...
US nears deal to fund Moderna's bird flu vaccine trial, FT reports
Colorado Springs Gazette· 5 days agoModerna told Reuters it was in discussions with the government on advancing its vaccine candidate,...
FDA approves Moderna’s mRNA RSV vaccine for older adults
KOMU Columbia· 3 days agoThe shot, made by Moderna and sold under the name of mResvia, could be another tool in the country’s...
Moderna's stock climbs on report that bird-flu vaccine funding is near
Morningstar· 5 days agoDepartment of Health and Human Services, could total several tens of millions of dollars and include a commitment to purchase vaccine doses if the trial is successful, the ...
Moderna wins second product approval with RSV vaccine
Morningstar· 4 days agoModerna Inc.'s respiratory syncytial virus vaccine for older adults received U.S. regulatory approval, the company said Friday, marking the first time a ...
Moderna’s RSV Shot Wins FDA Approval for Use in Older Adults
Bloomberg· 4 days agoModerna Inc. gained US approval for its RSV vaccine in older adults, giving the biotech company a...
Moderna Stock Is Having Another Very Bad Day. Here’s Why.
Barrons.com· 6 days agoThe stock’s drop comes as Moderna awaits important developments involving its experimental cancer...